Showing results (41-50 of 480) with videos related to
Sort By:
Pageof 48
Expert Opinion on Investigational Drugs|March 2, 2013
Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infectionDavid Alan Herbst, K Rajender ReddyThe Medical Clinics of North America|March 31, 2023
Liver Transplantation for the NonhepatologistBethany Nahri So, K Rajender ReddyClinics in Liver Disease|July 26, 2003
Hepatotoxicity of hypolipidemic drugsJavier L Parra, K Rajender ReddyClinics in Liver Disease|June 28, 2023
Liver Transplantation in Acute-on-Chronic Liver FailureAnand V Kulkarni, K Rajender ReddyClinics in Liver Disease|September 26, 2003
Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomesDavid E Kaplan, K Rajender ReddyClinics in Liver Disease|September 26, 2003
Factors that influence the severity of recurrent hepatitis C virus following liver transplantationSteven B Porter, K Rajender ReddyClinics in Liver Disease|July 25, 2009
Hepatitis C virus infection and immunomodulatory therapiesKimberly A Forde, K Rajender ReddyExpert Opinion on Investigational Drugs|August 13, 2013
NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infectionD Alan Herbst, K Rajender ReddyJournal of Viral Hepatitis|May 22, 2019
Use of HCV-infected organs in solid organ transplantation: An ethical challenge but plausible optionGayatri Nangia, Kelly Borges, K Rajender ReddyAlimentary Pharmacology & Therapeutics|January 29, 2019
Systematic review: epidemiology and response to direct-acting antiviral therapy in genotype 6 chronic hepatitis C virus infectionPanita Mettikanont, Chalermrat Bunchorntavakul, K Rajender ReddyPageof 48